Archer Materials Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARRXF research report →
Price Chart
About the company
Archer Materials Limited, a technology company, engages in development and commercialization of semiconductor devices and sensors related to quantum computing, medical diagnostics, TMR sensors, and lab-on-a-chip medical diagnostics in Australia. It offers qubit processor chip; and graphene-based lab-on-a-chip Biochip. The company was formerly known as Archer Exploration Limited and changed its name to Archer Materials Limited in October 2019.
- CEO
- Simon Ruffell
- IPO
- 2019
- Employees
- 23
- HQ
- Adelaide, SA, AU
Get TickerSpark's AI analysis on ARRXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $34.60M
- P/E
- -7.63
- PEG
- -2.30
- P/S
- 0.00
- P/B
- 4.50
- EV/EBITDA
- -4.95
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -51.46%
- ROIC
- -61.76%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $-101,004-104.9%
- Op Income
- $-9,143,215
- Net Income
- $-6,352,339+8.9%
- EPS
- $-0.03+8.8%
- OCF Growth
- -25.3%
- FCF Growth
- -25.9%
- 52W High
- $0.36
- 52W Low
- $0.10
- 50D MA
- $0.15
- 200D MA
- $0.22
- Beta
- -0.16
- RSI (14)
- 41
- Avg Volume
- 23.82K
No earnings-call transcripts are available for ARRXF yet.
- Free Float
- 77.3%
- Shares Outstanding
- 280.25M
- Float Shares
- 216.74M
Our ARRXF coverage
Recent articles, reports, and earnings notes.
No research on ARRXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ARRXF report →Nine Mile Metals signs market-making and media agreements
proactiveinvestors.com · Jul 3
Percheron Therapeutics targets one of oncology’s toughest problems: Why immunotherapy still falls short
proactiveinvestors.com · Nov 20
Cyprium board signs off on Nifty cathode restart, clearing path to mid-2026 production
proactiveinvestors.com · Nov 20
Archer advances towards single-qubit readout with key device milestone
proactiveinvestors.com · Nov 20
Orthocell advances Remplir™ prostate surgery opportunity as Australian use surpasses 100 cases
proactiveinvestors.com · Nov 20
Small Cap Watch: XSO extends declines, but there are company highlights
proactiveinvestors.com · Nov 20
Archer and EPFL Co-Develop a Single Chip Integrated Pulsed Electron Spin Resonance Microsystem
businesswire.com · Mar 24
Archer Materials ushers in use of quantum computing in mobile devices with latest 12CQ chip breakthrough
proactiveinvestors.com · Jan 31
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.